Skip navigation
Skip navigation

The cost-effectiveness of pneumococcal conjugate vaccination in Australia

Butler, James; McIntyre, Peter; MacIntyre, C Raina; Gilmour, Robin; Howarth, Ann; Sander, B


Background: Pneumococcal conjugate vaccine, 7 valent (PCV7) is the most costly vaccine yet considered for publicly funded programs. In mid 2001, Australia funded PCV7 for high-risk groups only (indigenous children and children with certain underlying medical conditions). World wide, non-industry-funded studies and studies using cost-utility measures are sparse. We undertook an independent economic analysis of PCV7 compared with no vaccination in the non high-risk Australian childhood population...[Show more]

CollectionsANU Research Publications
Date published: 2004
Type: Journal article
Source: Vaccine
DOI: 10.1016/j.vaccine.2003.09.036


There are no files associated with this item.

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator